BioSearch Inks Oligo Supply, License Deal with IMDx | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BioSearch Technologies today said that it has licensed patents covering oligonucleotide components to Intelligent Medical Devices (IMDx).

According to the Novato, Calif.-based firm, it has licensed to IMDx access to patents covering its BHQ, CAL Fluor, and Quasar technologies. It also will manufacture cGMP oligonucleotides for Cambridge, Mass.-based IMDx for human in vitro diagnostic use.

Financial and other terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.